|
1
|
Parkin DM and Bray F: Chapter 2. The
burden of HPV-related cancers. Vaccine. 24(Suppl 3): 11–25. 2006.
View Article : Google Scholar
|
|
2
|
Muñoz N, Bosch FX, de San José S, et al:
Epidemiologic classification of human papillomavirus types
associated with cervical cancer. N Engl J Med. 348:518–527.
2003.
|
|
3
|
Muñoz N, Castellsagué X, de González AB
and Gissmann L: HPV in the etiology of human cancer. Chapter 1.
Vaccine. 24(Suppl 3): S1–S10. 2006.
|
|
4
|
Walboomers JM, Jacobs MV, Manos MM, et al:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moscicki AB, Schiffman M, Kjaer S and
Villa LL: Updating the natural history of HPV and anogenital
cancer. Chapter 5. Vaccine. 24(Suppl 3): S42–S51. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Woodman CB, Collins SI and Young LS: The
natural history of cervical HPV infection: unresolved issues. Nat
Rev Cancer. 7:11–22. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schiffman M, Bauer HM, Hoover RN, et al:
Epidemiologic evidence showing that human papillomavirus infection
causes most cervical intraepithelial neoplasia. J Natl Cancer Inst.
85:958–964. 1993. View Article : Google Scholar
|
|
8
|
Petignat P, Faltin D, Goffin F, et al:
Age-related performance of human papillomavirus testing used as an
adjunct to cytology for cervical carcinoma screening in a
population with a low incidence of cervical carcinoma. Cancer.
105:126–132. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herrero R, Hildesheim A, Bratti C, et al:
Population-based study of human papillomavirus infection and
cervical neoplasia in rural Costa Rica. J Natl Cancer Inst.
92:464–474. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Molano M, Posso H, Weiderpass E, et al:
Prevalence and determinants of HPV infection among Colombian women
with normal cytology. Br J Cancer. 87:324–333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sweetnam P, Evans DM, Hibbard BM and Jones
JM: The Cardiff cervical cytology study. Prevalence and
epidemiology of cervical neoplasia. J Epidemiol Commun Health.
35:83–90. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murphy M, Goldblatt P, Thornton-Jones H
and Silcocks P: Survival among women with cancer of the uterine
cervix: influence of marital status and social class. J Epidemiol
Commun Health. 44:293–296. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krieger N, Quersenberry C Jr, Peng T, et
al: Social class, race/ethnicity and incidence of breast, cervix,
colon, lung and prostate cancer among Asian, Black, Hispanic and
White residents of the San Francisco Bay Area, 1988–1992 (United
States). Cancer Causes Control. 10:525–537. 1999.PubMed/NCBI
|
|
14
|
Thomas DB, Qin Q, Kuypers J, et al: Human
papillomavirus and cervical cancer in Bangkok. II Risk factors for
in situ and invasive squamous cell cervical carcinomas. Am J
Epidemiol. 153:732–739. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Parikh S, Brennan P and Boffetta P:
Meta-analysis of social inequality and the risk of cervical cancer.
Int J Cancer. 105:687–691. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McFadden K, McConnell D, Salmond C, et al:
Socioeconomic deprivation and the incidence of cervical cancer in
New Zealand: 1988–1998. N Z Med J. 117:U11722004.PubMed/NCBI
|
|
17
|
Hillard PI and Kahn JA: Understanding and
preventing human papillomavirus infection during adolescence and
young adulthood. J Adoles Health. 37:S1–S2. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Szostek S, Klimek M, Zawilinska B and
Kosz-Vnenchak M: Genotype-specific human papillomavirus detection
in cervical smears. A Bioch Polonica. 55:687–692. 2008.PubMed/NCBI
|
|
19
|
Lie AK and Kristensen G: Human
papillomavirus E6/E7 mRNA testing as a predictive marker for
cervical carcinoma. Rev Mol Diag. 8:405–415. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsumoto K: Human papillomavirus and
cervical cancer. Nipon Rinsho. 65:2113–2124. 2007.PubMed/NCBI
|
|
21
|
Meijer CJ, Snijders PJ and Castle PE:
Clinical utility of HPV genotyping. Gynecol Oncol. 103:12–17. 2006.
View Article : Google Scholar
|
|
22
|
Hwang HS, Park M, Lee SY, Kwon KH and Pang
MG: Distribution and prevalence of human papillomavirus genotypes
in routine pap smear of 2.470 Korean women determined by DNA chip.
Cancer Epidemiol Biomarkers Prev. 13:122004.PubMed/NCBI
|
|
23
|
Bosch FX, Manos MM, Muñoz N, et al:
Prevalence of human papillomavirus in cervical cancer: a worldwide
perspective. International biological study on cervical cancer
(IBSCC) study group. J Natl Cancer Inst. 87:796–802. 1995.
View Article : Google Scholar
|
|
24
|
Cuzick J, Sasíeni P, Davies P, et al: A
systematic review of the role of human papillomavirus (HPV) testing
within a cervical screening programme: summary and conclusions. Br
J Cancer. 83:561–565. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jacobs M, Snijders P, Voorhorst F, et al:
Reliable high risk HPV DNA testing by polymerase chain reaction: an
inter method and intra method comparison. J Clin Pathol.
52:498–503. 1999.PubMed/NCBI
|
|
26
|
Shafi MI: Management of women with mild
dyskaryosis. Cytological surveillance avoids treatment. Br Med J.
309:590–591. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Raffle AE, Alden B and Mackenzie EF:
Detection rates for abnormal cervical smear: what are we screening
for? Lancet. 345:1469–1473. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baldwin P, Laskey R and Coleman N:
Translational approaches to improving cervical screening. Nat Rev.
3:217–226. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Young L, Bevan I, Johnson M, et al: The
polymerase chain reaction. Br Med J. 298:14–18. 1989. View Article : Google Scholar
|
|
30
|
Hildesheim A, Schiffman MH, Gravitt P, et
al: Persistence of type-specific human papillomavirus infection
among cytologically normal women. J Infect Dis. 169:235–240. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ley C, Bauer H, Reingold A, et al:
Determinants of genital human papillomavirus infection in young
women. J Natl Cancer Inst. 83:997–1003. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liaw KL, Hsing AW, Chen CJ, et al: Human
papillomavirus and cervical neoplasia: a case-control study in
Taiwan. Int J Cancer. 62:565–571. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wheeler CM, Parmenter CA, Hunt WC, et al:
Determinants of genital human papillomavirus infection among
cytologically normal women attending the University of New Mexico
Student Health Center. Sex Transm Dis. 20:286–289. 1993. View Article : Google Scholar
|
|
34
|
Lazcano-Ponce E, Herrero R, Muñoz N, et
al: Epidemiology of HPV infection among Mexican women with normal
cervical cytology. Int J Cancer. 91:412–420. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thomas JO, Herrero R, Omigbodun AA, et al:
Prevalence of papillomavirus in women in Idaban, Nigeria: a
population-based study. Br J Cancer. 90:638–645. 2004. View Article : Google Scholar
|
|
36
|
De San José S, Amirall RL, Lloveras B, et
al: Cervical human papillomavirus infection in the female
population in Barcelona, Spain. Sex Transm Dis. 30:788–793.
2003.PubMed/NCBI
|
|
37
|
Cervantes J, Lema C, Hurtado L, et al:
Prevalence of human papillomavirus infection in rural villages of
Bolivian Amazon. Rev Inst Med Trop S Paulo. 45:131–135. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hibbitts S, Rieck GC, Hart K, et al: Human
papillomavirus infection: an anonymous prevalence study in South
Wales, UK. Br J Cancer. 95:226–232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bosch FX and de San José S: Human
papillomavirus and cervical cancer burden and assessment of
casuality. J Natl Cancer Inst Monogr. 31:3–13. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tarkowski TA, Koumans EH, Sawyer M, et al:
Epidemiology of human papillomavirus infection and abnormal
cytologic test result in an urban adolescent population. J Infect
Disease. 189:46–50. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Choi BS, Kim O, Park MS, Kim KS, Jeong JK
and Lee JS: Genital human papillomavirus genotyping by HPV
oligonucleotide microarray in Korean commercial sex workers. J Med
Virol. 71:440–445. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Camara GNL, Cerqueira DN, Oliveira APG, et
al: Prevalence of human papillomavirus types in woman with
pre-neoplastic and neoplastic cervical lesions in the Federal
District of Brazil. Mem Int Oswaldo Cruz. 98:1–11. 2003.
|
|
43
|
Jacobs MV, Walboomers JM, Snijkders PJ, et
al: Distribution of 37 mucosotropic HPV types in women with
cytologically normal cervical smears: the age-related patterns for
high-risk and low-risk types. Int J Cancer. 87:221–227. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Clifford GM, Smith JS, Plummer M, Muñoz N
and Francesschi S: Human papillomavirus types in invasive cervical
cancer worldwide: a meta-analysis. Br J Cancer. 88:63–73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Berumen J, Ordonez RM, Lazcano E, Salmeron
J, et al: Asian-American variants of human papillomavirus 16 and
risk for cervical cancer: a case-control study. J Nat Cancer Inst.
93:1325–1330. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sánchez-Anguiano LF, Alvarado-Esquivel C,
Reyes-Romero MA and Carrera-Rodríguez M: Human papillomavirus
infection in women seeking cervical papanicolaou cytology of
Durango, Mexico: prevalence and genotypes. BCM Infectious Diseases.
6–27. 2006.PubMed/NCBI
|
|
47
|
Stenvall H, Wikstrom I, Backlund I and
Wilander E: Accuracy of HPV testing of vaginal smear obtained with
a novel self-sampling device. Acta Obtetricia et Gynecologica.
86:16–21. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ho GY, Bierman R, Beardsley L, Chang CJ
and Burk RD: Natural history of cervical vaginal papillomavirus
infection in young women. N Engl J Med. 338:423–428. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ferreccio C, Prado RB, Luzoro AV, et al:
Population-based prevalence and age distribution of human
papillomavirus among women in Santiago-Chile. Cancer Epid,
Biomarkers and Prevention. 13:2271–2276. 2004.PubMed/NCBI
|
|
50
|
Kjellberg L, Hallmans G, Ahren A, et al:
Smoking, diet, pregnancy and oral contraceptive use as risk factors
for cervical intra epithelial neoplasia in relation to human
papillomavirus infection. Br J Cancer. 82:1332–1338.
2000.PubMed/NCBI
|
|
51
|
Chang-Claude J, Schneider A, Smith E,
Blettner M, Wahrendorf J and Turek L: Longitudinal study of the
effects of pregnancy and other factors on detection of HPV. Gynecol
Oncol. 60:355–362. 1996. View Article : Google Scholar : PubMed/NCBI
|
